Table 1.
Exposure-Adjusted Incidence Rate (EAIR) of Fall Events per Person-Year
| Phase | Placebo EAIR (n = 121)a | Duloxetine 60 mg EAIR (n = 249)b | Duloxetine 60/120 mg EAIR (n = 249)c |
| Acute | 0.69 | 0.95 | NA |
| Acute + continuation | 0.65 | 0.92 | 0.83 |
a
All patients who were exposed to placebo up to the time they were discontinued or completed the study or were switched to duloxetine.
b
All patients who were exposed to 60 mg up to the time they were discontinued or completed the study or were escalated to a higher dose.
c
All patients who were exposed to duloxetine regardless of dosage up to the time they were discontinued or completed the study.
Abbreviation: NA=not applicable.